The effect of inhaled leukotriene B4 in normal and in asthmatic subjects

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1789-1792

  Sampson, Sally E ^a   Costello, John F ^b   Sampson, Anthony P ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; HISTAMINE; LEUKOTRIENE B4; PLACEBO;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DESENSITIZATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG FUNCTION; MALE; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030949348     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154893     Document Type: Article

References (18)

1. Borgeat, P., and B. Samuelsson. 1979. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc. Natl. Acad. Sci. U.S.A. 76:2148-2152.
2. Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. H. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:254-265.
3. Fahy, J. V., K. K. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
4. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148:713-719.
5. Martin, R. J., L. C. Cicutto, H. R. Smith, R. D. Ballard, and S. J. Szefler. 1991. Airway inflammation in nocturnal asthma. Am. Rev. Respir. Dis. 143:351-357.
6. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihawa, P. Waltmann, and A. B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952-2959.
7. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J. Allergy. Clin. Immunol. 84:19-26.
8. Lam, S., H. Chan, J. C. LeRiche, M. Chan-Yeung, and H. Salari. 1988. Release of leukotrienes in patients with bronchial asthma. J. Allergy Clin. Immunol. 81:711-717.
9. Sampson, A. P., D. P. Castling, C. P. Green, and J. F. Price. 1995. Persistent elevation in plasma and urinary leukotrienes after acute asthma. Arch. Dis. Child. 73:221-225.
10. 4. Am. J. Respir. Cell Mol. Biol. 9:279-286.
11. 4. Prostaglandins 47:393-403.
12. 4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am. Rev. Respir. Dis. 140:1712-1715.
13. 4 antagonist LY293111 inhibits neutrophil recruitment to the airway and modulates inflammatory response following allergen challenge. Eur. J. Respir. 8(19):289s.
14. 4 in the human lung. J. Clin. Invest. 84:1609-1619.
15. 2 on bronchial responsiveness to histamine in normal subjects. Thorax 44:491-495.
16. Peters, M. J., A. J. X. Breslin, A. S. Kemp, J. Chu, and N. Berend. 1992. Haematological effects of inhalation of N-formyl-methionylleucyl-phenylalanine in man. Thorax 47:284-287.
17. 4. Lancet 342:465-469.
18. 4 and platelet activating factor in patients with inflammatory dermatoses. Clin. Exp. Immunol. 54:486-492.